Brenda Libby Coleman

Array ( [id] => 6702181 [patent_doc_number] => 20030225061 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Protease inhibitors' [patent_app_type] => new [patent_app_number] => 10/404142 [patent_app_country] => US [patent_app_date] => 2003-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 91848 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20030225061.pdf [firstpage_image] =>[orig_patent_app_number] => 10404142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7436568 [patent_doc_number] => 20040002487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Protease inhibitors' [patent_app_type] => new [patent_app_number] => 10/404716 [patent_app_country] => US [patent_app_date] => 2003-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 91817 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20040002487.pdf [firstpage_image] =>[orig_patent_app_number] => 10404716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7005774 [patent_doc_number] => 20050171087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Non-steroidal progesterone receptor modulators' [patent_app_type] => utility [patent_app_number] => 10/510275 [patent_app_country] => US [patent_app_date] => 2003-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29558 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20050171087.pdf [firstpage_image] =>[orig_patent_app_number] => 10510275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7367626 [patent_doc_number] => 20040006064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including those resistant to usual chemotherapeutic agents and as reversal agents' [patent_app_type] => new [patent_app_number] => 10/403506 [patent_app_country] => US [patent_app_date] => 2003-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41743 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20040006064.pdf [firstpage_image] =>[orig_patent_app_number] => 10403506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7216928 [patent_doc_number] => 20050054683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings' [patent_app_type] => utility [patent_app_number] => 10/470575 [patent_app_country] => US [patent_app_date] => 2003-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39268 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054683.pdf [firstpage_image] =>[orig_patent_app_number] => 10470575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6770436 [patent_doc_number] => 20030216376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => ' Crystalline forms of quetiapine hemifumarate' [patent_app_type] => new [patent_app_number] => 10/393929 [patent_app_country] => US [patent_app_date] => 2003-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10430 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20030216376.pdf [firstpage_image] =>[orig_patent_app_number] => 10393929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730857 [patent_doc_number] => 20030187047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Conformationally rigid bicyclic and adamantane derivatives useful as alpha2-adrenergic blocking agents' [patent_app_type] => new [patent_app_number] => 10/393313 [patent_app_country] => US [patent_app_date] => 2003-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7489 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20030187047.pdf [firstpage_image] =>[orig_patent_app_number] => 10393313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 489872 [patent_doc_number] => 07214673 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-08 [patent_title] => 'Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders' [patent_app_type] => utility [patent_app_number] => 10/505805 [patent_app_country] => US [patent_app_date] => 2003-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 82582 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/214/07214673.pdf [firstpage_image] =>[orig_patent_app_number] => 10505805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 472875 [patent_doc_number] => 07230021 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-12 [patent_title] => 'Potent, simplified derivatives of pateamine A' [patent_app_type] => utility [patent_app_number] => 10/388257 [patent_app_country] => US [patent_app_date] => 2003-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10097 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/230/07230021.pdf [firstpage_image] =>[orig_patent_app_number] => 10388257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5895449 [patent_doc_number] => 20060003988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Compounds capable of inhibiting immunocyte-related allergic immune reactions' [patent_app_type] => utility [patent_app_number] => 10/507580 [patent_app_country] => US [patent_app_date] => 2003-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 14200 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20060003988.pdf [firstpage_image] =>[orig_patent_app_number] => 10507580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7362067 [patent_doc_number] => 20040014744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Substituted pyridines having antiangiogenic activity' [patent_app_type] => new [patent_app_number] => 10/387367 [patent_app_country] => US [patent_app_date] => 2003-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38516 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014744.pdf [firstpage_image] =>[orig_patent_app_number] => 10387367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7105799 [patent_doc_number] => 20050107606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Process for producing optically active sulfoxide derivative' [patent_app_type] => utility [patent_app_number] => 10/506955 [patent_app_country] => US [patent_app_date] => 2003-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26902 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20050107606.pdf [firstpage_image] =>[orig_patent_app_number] => 10506955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7145611 [patent_doc_number] => 20050119250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Amino-derivatives as novel inhibitors of histone deacetylase' [patent_app_type] => utility [patent_app_number] => 10/507784 [patent_app_country] => US [patent_app_date] => 2003-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15760 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20050119250.pdf [firstpage_image] =>[orig_patent_app_number] => 10507784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6874899 [patent_doc_number] => 20030195196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-16 [patent_title] => 'Pyrrolobenzodiazepines' [patent_app_type] => new [patent_app_number] => 10/379049 [patent_app_country] => US [patent_app_date] => 2003-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 25595 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20030195196.pdf [firstpage_image] =>[orig_patent_app_number] => 10379049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 352694 [patent_doc_number] => 07491716 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-17 [patent_title] => 'Purine derivatives as kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/506459 [patent_app_country] => US [patent_app_date] => 2003-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59645 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/491/07491716.pdf [firstpage_image] =>[orig_patent_app_number] => 10506459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 463684 [patent_doc_number] => 07238686 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-03 [patent_title] => 'Polymorphs of quetiapine fumarate' [patent_app_type] => utility [patent_app_number] => 10/488628 [patent_app_country] => US [patent_app_date] => 2003-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 1777 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/238/07238686.pdf [firstpage_image] =>[orig_patent_app_number] => 10488628 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7005781 [patent_doc_number] => 20050171094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Pyrrolopyrimidine derivatives' [patent_app_type] => utility [patent_app_number] => 10/505228 [patent_app_country] => US [patent_app_date] => 2003-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55902 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20050171094.pdf [firstpage_image] =>[orig_patent_app_number] => 10505228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6822164 [patent_doc_number] => 20030220325 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Arylsulfone derivatives' [patent_app_type] => new [patent_app_number] => 10/371215 [patent_app_country] => US [patent_app_date] => 2003-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10964 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20030220325.pdf [firstpage_image] =>[orig_patent_app_number] => 10371215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 443346 [patent_doc_number] => 07256286 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-14 [patent_title] => 'Bryostatin analogues, synthetic methods and uses' [patent_app_type] => utility [patent_app_number] => 10/366776 [patent_app_country] => US [patent_app_date] => 2003-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60114 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/256/07256286.pdf [firstpage_image] =>[orig_patent_app_number] => 10366776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7040967 [patent_doc_number] => 20050159596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Cyclic compounds and their use as complex ligands' [patent_app_type] => utility [patent_app_number] => 10/503587 [patent_app_country] => US [patent_app_date] => 2003-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2707 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20050159596.pdf [firstpage_image] =>[orig_patent_app_number] => 10503587 [rel_patent_id] =>[rel_patent_doc_number] =>)